TNFSF10 and cancer: In addition, Mitchell et al [24] recently developed a unique approach, in which circulating leukocytes with the adherent E-selectin/TRAIL liposomes were effective in killing cancer cells both in vitro with human blood samples and in vivo, in the mouse bloodstream.